Anne Danø
8PUBLICATIONS
17CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (8)
Sort by Publication Date:
|Sep 19, 2023
Axicabtagene ciloleucel compared to standard of care in Swedish patients with large B-cell lymphoma: a cost-effectiveness analysis of the ZUMA-7 trial.Anne Sofie Ledgaard Loftager, Anne Danø, Oskar Eklund
|Aug 03, 2023
The Cost-Effectiveness of Anti-IL17 Biologic Therapies for Moderate-to-Severe Plaque Psoriasis Treatment in Italy and Germany: A Sequential Treatment Analysis.Nanna Nyholm, Anne Danø, Henrik Schnack
|May 19, 2023
Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany.Nanna Nyholm, Henrik Schnack, Anne Danø
|Mar 31, 2023
Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies.Mikkel H Pedersen, Anne Danø, Ebbe Englev
|Sep 29, 2022
Administration and patient-incurred costs associated with opioid agonist treatment in Norway.Mikkel H Pedersen, Anne Danø, Carl Gibbons
Pageof 2
Frequent Collaborators
3 joint publications
Mikkel H Pedersen
2 joint publications
Emma Munk
2 joint publications
Nanna Nyholm
2 joint publications
Henrik Schnack
1 joint publications
Alexander Egeberg
1 joint publications
Anne Sohrt
1 joint publications
Emma Borg
1 joint publications
Adam Reich
1 joint publications
Sandra Elkjaer Stallknecht
1 joint publications
Anthony Bewley